Outcome of Board Meeting held on 5th June, 2026 pursuant to Regulation 30 and other applicable provisions of the SEBI (LODR) Regulations, 2015 .
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The Board of Directors of Boston Commerce Ltd met on 5th June 2026 and approved the initiation of two significant corporate actions. First, the Board recommended starting the process for a Scheme to confirm and write off certain assets that are not readily realisable, which is subject to shareholder and regulatory approval. Second, the Board approved the initiation of a Scheme of Capital Reduction, which will be taken to an Extraordinary General Meeting (EGM) for shareholder consideration. The detailed write-off scheme is still under preparation and will be shared with shareholders once finalized. The company was formerly known as Boston Bio Systems Limited.
For shareholders, this is a balance sheet cleanup exercise — the write-off removes non-realisable assets while the capital reduction will likely reduce share capital, which could affect share value or face value. Investors should watch for the EGM notice and the final scheme details to assess the impact on their holdings.